Dosing begins in first-in-human study of UCARTCS1 for relapsed/refractory multiple myeloma Oct. 30, 2019
Dalian Institute of Chemical Physics CAS patents muscarinic M1/ M3 receptor antagonists Oct. 30, 2019
East China University of Science and Technology patents dihydroorotate dehydrogenase inhibitors Oct. 30, 2019